A case series analysis of serious exacerbations of viral hepatitis and non‐viral hepatic injuries in tocilizumab‐treated patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A case series analysis of serious exacerbations of viral hepatitis and non‐viral hepatic injuries in tocilizumab‐treated patients

Published:2020-12-31 Issue:3 Volume:41 Page:515-528
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Biehl Ann¹^ORCID,Harinstein Lisa¹,Brinker Allen¹,Glaser Rachel²,Muñoz Monica¹,Avigan Mark¹

Affiliation:

1. Office of Pharmacovigilance and Epidemiology US FDA Center for Drug Evaluation and Research Silver Spring MD USA

2. Division of Rheumatology and Transplant Medicine Office of New Drugs US FDA Center for Drug Evaluation and Research Silver Spring MD USA

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14766

Reference49 articles.

1. COVID-19: consider cytokine storm syndromes and immunosuppression

2. Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report

3. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

4. Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of drug-induced liver injury after the administration of tocilizumab for adult Still's disease;Kanzo;2024-08-01

2. The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis;Viruses;2024-01-03

3. Ruxolitinib rescued the macrophage activation syndrome in adult-onset Still’s disease with delayed hypersensitivity reaction to tocilizumab;Rheumatology;2022-12-15

4. Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus;Internal Medicine;2022-07-01

5. Management of hepatitis B virus reactivation due to treatment of COVID-19;Hepatology International;2022-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3